Jefferies Reiterates MedAssets Rating

Jefferies & Company said today that it is reiterating its Hold rating on shares of MedAssets, Inc. MDAS. “We continue to believe that MDAS is well positioned in the healthcare market with a focus on cost-savings and revenue cycle,” Jefferies writes. “However, with moving parts such as Broadlane and caution on revenue cycle transformation deals, we believe that the stock is range bound until more clarity emerges.” MedAssets currently trades at $18.55.